Skip to main content

FreeCME
About Us
Sign Up|Log In

FreeCME
About Us
All Products

Sign Up|Log In

Browse by Speciality Area

Hospital Medicine
Cardiology
Risk Management
Emergency Medicine
Infectious Disease
Internal Medicine
Neurology
Primary Care
Medical Ethics
Pediatrics

Browse by Product Type

Subscription Publications
Books & Study Guides

All Access Subscription

Get unlimited access to our full publication and article library.

Interested in Group Sales? Learn more

Home
Cancer Research Alert Archives
December 1, 2000

National Institutes of Health: Innovative Toxicology Models for Drug Evaluation

December 1, 2000

Issue Date: December 1, 2000

Table of Contents

Human Heparanase: A Molecular Determinant of Tumor Metastasis and Angiogenesis
Hypermethylation of TPEF in Human Cancers
Carboxylesterase-Mediated Activation of Irinotecan
National Institutes of Health: Innovative Toxicology Models for Drug Evaluation

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Shop Now: Search Products

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements

Emergency
Hospital
Clinical
All Access
Help
Search
About Us
Newsletters
FreeCME

The trusted source for healthcare information and CONTINUING EDUCATION.

ACCOUNTS RECEIVABLE

MAILING ADDRESS

1010 Sync St., Suite 100

Morrisville, NC 27560-5468

USA

© 2025 Relias. All rights reserved.

Do Not Sell My Personal Information
Privacy Policy
Terms Of Use
Help
Group Sales

For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

We use cookies to create a better experience. By continuing to use our site, you consent to the use of cookies outlined in our Privacy Policy.

Close Banner